Company history

Zymenex was founded in 1998 by Dr. Jens Fogh and Dr. Pär Gellerfors, and in 2013 was acquired by Chiesi Group. It specializes in the research and development of recombinant therapeutic enzymes for rare genetic diseases.

Zymenex has its headquarters in the prestigious Medicon Valley in Hillerød, north of Copenhagen, and R&D facilities in Lidingö in Stockholm.

All administrative functions including regulatory, quality assurance and project management are located in Hillerød.

The Research laboratory in Lidingö specializes in early product and analytical development. This includes characterization of the expressed clones, development of upstream and down-stream processes, formulation development, development of methods of analysis and development of new product concepts and technologies.

Through a consolidated network of contract manufacturers in Sweden, Denmark, and Germany, Zymenex controls the manufacturing of pre-clinical and clinical material, including product release.
Being part of an international Group allows the Company to benefit from the great Chiesi R&D know-how in all stages of drug development.

Zymenex A/S Roskildevej 12 C
3400 Hillerød, DK
Tel  +45 48250054
Fax  +45 48251054
Affiliate Sweden Agavägen 58
181 55 Lidingö, S
Tel  +46 8 7670203
Fax  +46 8 7670233

© 2004 Zymenex A/S